相关实验视频

Updated: Jul 25, 2025

Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes

Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes

Published on: June 3, 2018

关于激活转录因子3的研究进展:一个有前途的心脏保护分子

Haoteng Ke¹, Zexing Chen¹, Xuanbin Zhao¹

¹The Second School of Clinical Medicine, Southern Medical University, Guangzhou 510280, China; Zhujiang Hospital, Southern Medical University, Guangzhou 510280, China.

|June 24, 2023

概括

激活转录因子3 (ATF3) 通过调节氧化应激,新陈代谢和细胞死亡,在心血管疾病中表现出保护作用. 这篇评论探讨了ATF3的功能.

科学领域:

心血管生物学心血管生物学
分子心脏病学分子心脏病学
应激反应机制应激反应机制

背景情况:

激活转录因子3 (ATF3) 是由各种压力引起的.
在心血管疾病中,ATF3具有复杂的作用,有时是有害的,有时是保护性的.
之前的研究强调了ATF3参与动脉样硬化,缩,纤维化和缺血-再输血损伤.

研究的目的:

审查ATF3在心脏功能障碍中的保护作用和机制.
探索ATF3对心血管疾病的治疗潜力.
提供使用ATF3.3预防和治疗心脏病的证据.

主要方法:

对ATF3和心血管疾病研究的文献综述.
分析ATF3在氧化应激,脂质和能量代谢以及细胞死亡中的作用.
对ATF3的心脏保护功能进行当前研究的综合.

主要成果:

在抗氧化压力中,ATF3显示出心脏保护作用.
ATF3 影响心脏中的脂质和能量代谢调节.
ATF3调节细胞死亡途径,有助于心脏保护.

结论:

ATF3 具有显著的心脏保护性.
了解ATF3机制可能为心血管疾病提供新的治疗策略.
对ATF3的进一步研究可能会导致治疗心脏功能障碍的新方法.

关键词:

在ATF3中使用ATF3.心血管疾病的心血管疾病.机制机制机制治疗疗法治疗疗法

更多相关视频

Improved Generation of Induced Cardiomyocytes Using a Polycistronic Construct Expressing Optimal Ratio of Gata4, Mef2c and Tbx5

Improved Generation of Induced Cardiomyocytes Using a Polycistronic Construct Expressing Optimal Ratio of Gata4, Mef2c and Tbx5

Published on: November 13, 2015

Assessing Cardiac Reprogramming using High Content Imaging Analysis

Assessing Cardiac Reprogramming using High Content Imaging Analysis

Published on: October 26, 2020

相关概念视频

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...